CVE-2018-14787 describes a privilege escalation vulnerability in Philips IntelliSpace Cardiovascular (ISCV) products (versions 2.x or prior) and Xcelera (versions 4.1 or prior). An attacker with existing escalated privileges could exploit write permissions in executable folders to execute arbitrary code with local administrative rights. This vulnerability carries a CVSS score of 7.8 (High), indicating a local attack vector with low complexity, leading to high impact on confidentiality, integrity, and availability. There is no evidence of active exploitation, publicly available exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion or media coverage surrounding this CVE.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
<= 3.1CPE matchmatch criteria | cpe:2.3:a:philips:intellispace_cardiovascular:*:*:*:*:*:*:*:* | ||
<= 4.1CPE matchmatch criteria | cpe:2.3:a:philips:xcelera:*:*:*:*:*:*:*:* |
CVSS version used by this source: 3.1
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.2 Bluesky, 0.1 Mastodon, and 0.2 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.3 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.